Clinical and Experimental Studies on Chronic Obstructive Pulmonary Diseases Treated by Fufang Xiebai Capsule, Report of 36 cases

doi:10.13288/j.11-2166/r.2000.04.022

您当前的位置：

首页 >

文章列表页 >

Clinical and Experimental Studies on Chronic Obstructive Pulmonary Diseases Treated by Fufang Xiebai Capsule, Report of 36 cases

更新时间：2021-11-20

- Clinical and Experimental Studies on Chronic Obstructive Pulmonary Diseases Treated by Fufang Xiebai Capsule, Report of 36 cases
- Journal of Traditional Chinese Medicine Issue 4, Pages: 218-220(2000)
- 作者机构：
  
  1. 江苏省中医院全国中医急症中心
  2. 江苏省中医院心肺功能室
  3. 江苏省中医院呼吸科
  4. 江苏省中医院药剂科南京市汉中路155号,210029
- 作者简介：
- 基金信息：
- DOI：10.13288/j.11-2166/r.2000.04.022
  CLC： R259.6
- Published：2000
- 稿件说明：
移动端阅览
[1]奚肇庆,蒋萌,居文政,孙子凯,洪建军,曹阳,周江,张彪,冷报浪,曹世宏.复方薤白胶囊治疗慢性阻塞性肺病36例临床与实验研究[J].中医杂志,2000(04):218-220+196.

Clinical and Experimental Studies on Chronic Obstructive Pulmonary Diseases Treated by Fufang Xiebai Capsule, Report of 36 cases[J]. Journal of Traditional Chinese Medicine2000, (4): 218-220.
[1]奚肇庆,蒋萌,居文政,孙子凯,洪建军,曹阳,周江,张彪,冷报浪,曹世宏.复方薤白胶囊治疗慢性阻塞性肺病36例临床与实验研究[J].中医杂志,2000(04):218-220+196. DOI： 10.13288/j.11-2166/r.2000.04.022.

Clinical and Experimental Studies on Chronic Obstructive Pulmonary Diseases Treated by Fufang Xiebai Capsule, Report of 36 cases[J]. Journal of Traditional Chinese Medicine2000, (4): 218-220. DOI： 10.13288/j.11-2166/r.2000.04.022.

摘要

复方薤白胶囊治疗慢性阻塞性肺病（慢阻肺）及肺动脉高压症36例

与对照组比较

对咳痰、喘息及哮鸣音等症状和体征的改善有显著性差异（P

0.05）

总有效率91.7％。并有明显改善肺通气功能和降低肺动脉压作用。动物实验表明

复方薤白胶囊能提高大鼠血浆PGI

含量

抑制TXA

与心痛定组比较

可明显改善肺血管重组和减轻右心肥厚的病理。提示通阳宣痹法有止咳化痰

解痉平喘和降低肺动脉压作用。

Abstract

Thirty - six cases were treated with Fufang Xiebai （FX） capsule and compared with control group. There was significant difference （P<0. 05） in the amelioration of signs and symptoms such as coughing

asthma

and wheezing rales

the total effective rate being 91. 7%. It also improved the ventilation of the lungs and lowered the pulmonary arterial pressure. Animal experiments revealed that FX increased the contents of plasma PGI2

inhibit TXA2 in rats. When compared with the control group treated with nifedipine

it markedly improved the re -organization of pulmonary vessels and decreased the pathology of right heart hypertrophy

indicating that the methods of communicating Yang and eliminating Bi - syndrome yielded actions of antitussive and depressing cough

releasing spasm and eliminating asthma

and lowering pulmonary hypertension.

关键词

Keywords

references

查看原文

Views

228

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Construction and Application of "Source-Pivot-Convergence" Pattern Identification and Treatment Model for Malignant Tumors

Exploring the Comorbidity Mechanism，Prevention and Treatment Strategies of Rheumatoid Arthritis with Coronary Atherosclerotic Heart Disease Based on Collateral Disease Theory

Construction and Application of a Real-World Cohort of Community-Acquired Pneumonia Based on a Multimodal Large-Scale Traditional Chinese Medicine Big Data Platform

Efficacy and Economic Evaluation of Weishi Qingjin Formula （苇石清金方）in the Treatment of Adult Community-Acquired Pneumonia with Phlegm-Heat Obstructing the Lung Syndrome：A Multicenter Retrospective Real-World Cohort Study

LI Guolie's Experience in Treating Orthostatic Hypotension from the Perspective of "Raising the Clear and Directing the Turbid Downward"

Related Author

No data

Related Institution

No data

Address：No.16, Nanxiao street, Dongzhimen, Dongcheng District, Beijing Postal code：100700
Tel：010-64035632 Email：jtcmcn@188.com
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备09064830号-19 京公网安备11010102007558号
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰